Profil
Željko Prijović
Zvanje:
Naučni saradnik
Direktni telefoni:
+381643161828
Lokal:
Naučna oblast:
1
Veće oblasti:
Hemija,
Orcid broj:
Organizaciona jedinica:
070
DIPLOME
ZVANJA
M faktor
| Kategorija | Broj | Koeficijent | Ukupno |
|---|
Ukupno M faktor:
0
NI radovi
| # | Naziv, Datum, Grupa, Vrsta | Godina | Autori | Status | |
|---|---|---|---|---|---|
| 1 |
177Lu–labeled micro liposomes as a potential radiosynoviorthesis therapeutic agent
International Journal of Pharmaceutics , , 2021 M20 | M21 |
2021 | Đorđe Cvjetinović, Drina Janković, Zorana Milanović, Marija Mirković, Jelena Petrović, Željko Prijović, Emiliya Pogohysan, SanjaVranješ–Đurić |
Odobren
|
|
| 2 |
90Y-CA/SPIONs for dual magnetic hyperthermia-radionuclide nanobrachytherapy of solid tumours
Nanotechnology , , 2022 M20 | M21 |
2022 | Aleksandar Vukadinović, Zorana Milanović, Miloš Ognjanović, Drina Janković, Magdalena Radović, Marija Mirković, Maria-Argyro Karageorgou, Penelope Bouziotis, Slavica Erić, Sanja Vranješ-Đurić, Bratislav Antić, Željko Prijović |
Odobren
|
|
| 3 |
Aminosilanized flower-structured superparamagnetic iron oxide nanoparticles coupled to 131I-labeled CC49 antibody for combined radionuclide and hyperthermia therapy of cancer
International Journal of Pharmaceutics , , 2020 M20 | M21 |
2020 | Aljoša Stanković, Jasna Mihailović, Marija Mirković, Magdalena Radović, Zorana Milanović, Miloš Ognjanović, Drina Janković, Bratislav Antić, Milica Mijović, Sanja Vranješ-Đurić, Željko Prijović |
Odobren
|
|
| 4 |
177Lu-doxycycline as potential radiopharmaceutical: electrochemical characterization, radiolabeling, and biodistribution in tumor-bearing mice
International Journal of Radiation Biology , , 2021 M20 | M21a |
2021 | Zorana Milanović,Drina Janković,Sanja Vranješ-Đurić,Magdalena Radović,Željko Prijović,Gordana Zavišić,Marko Perić,Dalibor Stanković & Marija Mirković |
Odobren
|
|
| 5 |
Bioevaluation of glucose-modified liposomes as a potential drug delivery system for cancer treatment using 177-Lu radiotracking
JOURNAL OF CONTROLLED RELEASE , , 2021 M20 | M21a |
2021 | Cvjetinovic Djordje, Prijovic Zeljko, Jankovic Drina Lj, Radovic Magdalena Z, Mirkovic Marija D, Milanovic Zorana, Mojovic Milos D, Skalamera Đani, Vranjes-Djuric Sanja D |
Odobren
|
|
| 6 |
Magnetically induced controlled release from glucose-modified liposomes loaded with Fe3O4 nanoparticles
Journal of Nanoparticle Research , , 2021 M20 | M22 |
2021 | Đorđe Cvjetinović, Zorana Milanović, Marija Mirković, Jelena Petrović, Ana Vesković, Ana Popović-Bijelić, Željko Prijović, Drina Janković, Sanja Vranješ-Đurić |
Odobren
|
|
| 7 |
Radiolabeled magnetic nanoparticles for cancer theranostics
Materials Science and Engineering (MSE) , Darmstadt, Germany , 2020 M30 | M32 |
2020 | Marija Mirković, Aljoša Stanković, Sanja Vranješ-Đurić, Drina Janković, Zorana Milanović, Magdalena Radović, Miloš Ognjanović, Bratislav Antić, Milica Mijović, Željko Prijović |
Dupli unos, za brisanje
|
|
| 8 |
BQC-G, a tumor-selective anti-cancer prodrug
US Patent Office , USA , 2016 M90 | M91 |
2016 | Zeljko M. Prijovic, Yu-Lin Leu and Steve Roffler |
Odobren
|
|
| 9 |
Human beta-glucuronidase mutants with elevated enzymatic activity under physiological conditions and method for identifying such
US Patent office , USA , 2013 M90 | M91 |
2013 | Steve Roffler, Chia-Hung Wu, Wolfgang Schechinger, Kai-Chuan Chen, Zeljko M. Prijovic |
Odobren
|
|
| 10 |
Synthesis and Antitumor Properties of BQC-Glucuronide, a Camptothecin Prodrug for Selective Tumor Activation
Molecular Pharmaceutics , , 2016 M20 | M21 |
2016 | Zeljko M. Prijovich, Pierre-Alain Burnouf, Hua-Cheng Chou, Ping-Ting Huang, Kai-Chuan Chen, Tian-Lu Cheng, Yu-Lin Leu, Steve R. Roffler |
Odobren
|
|
| 11 |
Mast cells mediate malignant pleural effusion formation
Journal of Clinical Investigation , , 2015 M20 | M21a |
2015 | Anastasios D. Giannou, Antonia Marazioti, Magda Spella, Nikolaos I. Kanellakis, Hara Apostolopoulou, Ioannis Psallidas, Zeljko M. Prijovich, Malamati Vreka, Dimitra E. Zazara, Ioannis Lilis, Vassilios Papaleonidopoulos, Chrysoula A. Kairi, Alexandra L. Patmanidi, Ioanna Giopanou, Nikolitsa Spiropoulou, Vaggelis Harokopos, Vassilis Aidinis, Dionisios Spyratos, Stamatia Teliousi, Helen Papadaki, Stavros Taraviras, Linda A. Snyder, Oliver Eickelberg, Dimitrios Kardamakis, Yoichiro Iwakura, Thorsten B. Feyerabend, Hans-Reimer Rodewald, Ioannis Kalomenidis, Timothy S. Blackwell, Theodora Agalioti, Georgios T. Stathopoulos |
Odobren
|
|
| 12 |
Versatile online SPE-HPLC method for the analysis of Irinotecan and its clinically relevant metabolites in biomaterials
Journal of Separation Science , , 2014 M20 | M23 |
2014 | Zeljko M. Prijovich, Pierre-Alain Burnouf, Steve R. Roffler |
Odobren
|
|
| 13 |
The B7-1 Cytoplasmic Tail Enhances Intracellular Transport and Mammalian Cell Surface Display of Chimeric Proteins in the Absence of a Linear ER Export Motif
PLoS ONE , , 2013 M20 | M21 |
2013 | Yi-Chieh Lin, Bing-Mae Chen, Wei-Cheng Lu, Chien-I Su, Zeljko M. Prijovich, Wen-Chuan Chung, Pei-Yu Wu, Kai-Chuan Chen, I-Chiao Lee, Ting-Yi Juan, Steve R. Roffler |
Odobren
|
|
| 14 |
ECSTASY, an adjustable membrane-tethered/soluble protein expression system for the directed evolution of mammalian proteins
Protein Engineering Design and Selection , , 2012 M20 | M22 |
2012 | C.-P. Chen, Y.-T. Hsieh, Z. M. Prijovich, H.-Y. Chuang, K.-C. Chen, W.-C. Lu, Q. Tseng, Y.-L. Leu, T.-L. Cheng, S. R. Roffler |
Odobren
|
|
| 15 |
A Humanized Immunoenzyme with Enhanced Activity for Glucuronide Prodrug Activation in the Tumor Microenvironment
Bioconjugate Chemistry , , 2011 M20 | M22 |
2011 | Kai-Chuan Chen, Shih-Yen Wu, Yu-Lin Leu, Zeljko M. Prijovich, Bing-Mae Chen, Hsin-Ell Wang, Tian-Lu Cheng, Steve R. Roffler |
Za izmenu
|
|
| 16 |
Enhancement of CPT-11 antitumor activity by adenovirus-mediated expression of β–glucuronidase in tumors
Cancer Gene Therapy , , 2011 M20 | M22 |
2011 | P-T Huang, K-C Chen, Z M Prijovich, T-L Cheng, Y-L Leu, S R Roffler |
Odobren
|
|
| 17 |
Antiangiogenesis Targeting Tumor Microenvironment Synergizes Glucuronide Prodrug Antitumor Activity
Clinical Cancer Research , , 2009 M20 | M21a |
2009 | Ting-Yi Juan, Steve R. Roffler, Hsien-San Hou, Shih-Ming Huang, Kai-Chuan Chen, Yu-Lin Leu, Zeljko M. Prijovich, Cheng-Ping Yu, Chang-Chieh Wu, Guang-Huan Sun, Tai-Lung Cha |
Odobren
|
|
| 18 |
Local enzymatic hydrolysis of an endogenously generated metabolite can enhance CPT-11 anticancer efficacy
Molecular Cancer Therapeutics , , 2009 M20 | M22 |
2009 | Zeljko M. Prijovich, Kai-Chuan Chen, Steve R. Roffler |
Odobren
|
|
| 19 |
Directed Evolution of a Lysosomal Enzyme with Enhanced Activity at Neutral pH by Mammalian Cell-Surface Display
Chemistry & Biology , , 2008 M20 | M22 |
2008 | Kai-Chuan Chen, Chia-Hung Wu, Chuan-Yuan Chang, Wei-Cheng Lu, Qingzong Tseng, Zeljko M. Prijovich, Wolfgang Schechinger, Yen-Chywan Liaw, Yu-Lin Leu, Steve R. Roffler |
Za izmenu
|
|
| 20 |
Effect of pH and human serum albumin on the cytotoxicity of a glucuronide prodrug of 9-aminocamptothecin
Cancer Chemotherapy and Pharmacology , , 2006 M20 | M22 |
2006 | Zeljko M. Prijovich, Yu-Lin Leu, Steve R. Roffler |
Odobren
|
|
| 21 |
Membrane-localized activation of glucuronide prodrugs by β-glucuronidase enzymes
Cancer Gene Therapy , , 2006 M20 | M23 |
2006 | K-C Chen, T-L Cheng, Y-L Leu, Z M Prijovich, C-H Chuang, B-M Chen, S R Roffler |
Odobren
|
|
| 22 |
EFFICACY OF 177LU‐ AND 90Y‐LABELED NANOPARTICLES IN TARGETED TUMOR THERAPY IN A MOUSE CT26 AND 4T1 XENOGRAFT MODEL
VIII Kongres farmaceuta Srbije sa međunarodnim učešćem, 12-15. oktobar 2022., Beograd , Beograd , 2022 M30 | M34 |
2022 | Dragana Stanković, Drina Janković, Marija Mirković, Magdalena Radović, Zorana Milanović, Aleksandar Vukadinović, Aljoša Stanković, Marko Perić, Sanja Vranješ-Đurić, Željko Prijović, Miroslav Savić |
Odobren
|
|
| 23 |
BIOLOGICAL BEHAVIOUR OF 90Y‐LABELED MICRO‐ AND NANOPARTICLES IN TUMOR‐BEARING MICE
VIII Kongres farmaceuta Srbije sa međunarodnim učešćem, 12-15. oktobar 2022. , Beograd , 2022 M30 | M34 |
2022 | Aleksandar Vukadinović, Nikola Knežević, Drina Janković, Magdalena Radović, Marko Perić, Marija Mirković, Zorana Milanović, Dragana Stanković, Sanja Vranješ‐Đurić, Željko Prijović, Slavica Erić |
Odobren
|
|
| 24 |
Synthesis, Characterization, and Therapeutic Efficacy of 177Lu-DMSA@SPIONs in Nanobrachytherapy of Solid Tumors
Pharmaceutics , , 2023 M20 | M21 |
2023 | Dragana Stanković, Magdalena Radović, Aljoša Stanković, Marija Mirković, Aleksandar Vukadinović, Milica Mijović, Zorana Milanović, MILOŠ OGNJANOVIĆ, Drina Janković, BRATISLAV ANTIĆ, Sanja Vranješ-Đurić, Miroslav Savić, Željko Prijović |
Odobren
|
|
| 25 |
Co(III), Ni(II) and Cu(II) complexes with a tetradentate Schiff base ligand: synthesis, characterization, electrochemical behavior, binding assessment and in vitro cytotoxicity
Journal of Coordination Chemistry , , 2022 M20 | M22 |
2022 | Marija Mirković, Magdalena Radović, Dalibor Stanković, Sanja Vranješ-Đurić, Drina Janković, Djordje Petrović, Ljiljana E. Mihajlović-Lalić, Željko Prijović, Zorana Milanović |
Odobren
|
|
| 26 |
Therapeutic Efficacy of [ 177Lu]Lu‑DMSA‑SPIONs in a Mouse CT26 and 4T1 Xenograft Model
21st European Symposium on Radiopharmacy and Radiopharmaceuticals (ESRR’24) , Coimbra, Portugal , 2024 M30 | M34 |
2024 | Dragana Stanković, Magdalena Radović, Marija Mirković, Zorana Milanović, Aljoša Stanković, Milica Mijović, Miloš Ognjanović, Drina Janković, Aleksandar Vukadinović, Bratislav Antić, Sanja Vranješ‑Ðurić, Miroslav Savić, Željko Prijović |
Odobren
|